1. Home
  2. SLP vs PFLT Comparison

SLP vs PFLT Comparison

Compare SLP & PFLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLP
  • PFLT
  • Stock Information
  • Founded
  • SLP 1996
  • PFLT 2010
  • Country
  • SLP United States
  • PFLT United States
  • Employees
  • SLP N/A
  • PFLT N/A
  • Industry
  • SLP EDP Services
  • PFLT Finance: Consumer Services
  • Sector
  • SLP Technology
  • PFLT Finance
  • Exchange
  • SLP Nasdaq
  • PFLT Nasdaq
  • Market Cap
  • SLP 675.9M
  • PFLT 808.2M
  • IPO Year
  • SLP 1997
  • PFLT N/A
  • Fundamental
  • Price
  • SLP $26.37
  • PFLT $10.12
  • Analyst Decision
  • SLP Buy
  • PFLT Buy
  • Analyst Count
  • SLP 8
  • PFLT 5
  • Target Price
  • SLP $47.83
  • PFLT $11.20
  • AVG Volume (30 Days)
  • SLP 296.7K
  • PFLT 924.2K
  • Earning Date
  • SLP 07-01-2025
  • PFLT 05-12-2025
  • Dividend Yield
  • SLP 0.23%
  • PFLT 12.17%
  • EPS Growth
  • SLP N/A
  • PFLT N/A
  • EPS
  • SLP 0.36
  • PFLT 0.86
  • Revenue
  • SLP $78,564,000.00
  • PFLT $232,975,000.00
  • Revenue This Year
  • SLP $30.21
  • PFLT $48.14
  • Revenue Next Year
  • SLP $11.83
  • PFLT $9.03
  • P/E Ratio
  • SLP $73.23
  • PFLT $11.73
  • Revenue Growth
  • SLP 21.49
  • PFLT 49.56
  • 52 Week Low
  • SLP $23.01
  • PFLT $8.82
  • 52 Week High
  • SLP $50.11
  • PFLT $12.02
  • Technical
  • Relative Strength Index (RSI)
  • SLP 31.23
  • PFLT 48.41
  • Support Level
  • SLP $31.79
  • PFLT $9.78
  • Resistance Level
  • SLP $34.01
  • PFLT $10.35
  • Average True Range (ATR)
  • SLP 1.64
  • PFLT 0.17
  • MACD
  • SLP -0.40
  • PFLT 0.02
  • Stochastic Oscillator
  • SLP 0.78
  • PFLT 58.33

About SLP Simulations Plus Inc.

Simulations Plus Inc is engaged in the software industry. It includes two segments. It develops and produces software for use in pharmaceutical research and education, and provides consulting and contract research services to the pharmaceutical industry. The company's operating segments include Software and services. The company offers software products for pharmaceutical research such as ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity). It generates maximum revenue from the software segment. Maximum revenue is earned from USA following EMEA and Asia Pacific.

About PFLT PennantPark Floating Rate Capital Ltd.

PennantPark Floating Rate Capital Ltd is a closed-end, externally managed, non-diversified investment company. Its investment objectives are to generate current income and capital appreciation by investing in Floating Rate Loans and other investments made to U.S. middle-market companies. The company believes that Floating Rate Loans to U.S. middle-market companies offer attractive risk-reward to investors due to the limited amount of capital available for such companies and the potential for rising interest rates. The company generate revenue in the form of interest income on the debt securities and dividends.

Share on Social Networks: